Treatment Outcomes and Toxicities for Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab

Authors
Category Primary study
ConferenceMedical Oncology Group of Australia Incorporated Annual Scientific Meeting
Year 2024
This article has no abstract
Epistemonikos ID: c51fecda8f70773bada224b0b325e1072076fc1c
First added on: Dec 13, 2025